CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

2.500

+0.370 (17.37%)

At close: May 13, 2025, 4:00 PM

2.390

-0.110 (-4.40%)

Pre-market: May 14, 2025, 5:46 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Probody Therapeutics	101.21M	Log In	Log In	Log In	Log In	Upgrade
Probody Therapeutics Growth	90.38%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	101.21M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	90.38%	Log In	Log In	Log In	Log In	Upgrade